JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
NCT06412848
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
360
Enrollment
INDUSTRY
Sponsor class
Conditions
Urothelial Carcinoma
Interventions
DRUG:
Avelumab
Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany